Physician profile
Edward Chu
NPI 1487640272
$4,621.73
in general payments reported to CMS, 2019-2025
28 companies · $473 in 2025
The $473 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $246 · 2021: $212 · 2022: $604 · 2023: $1,198 · 2024: $1,087 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,673 · Travel and Lodging: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,673.02 |
| Travel and Lodging | $1,085.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,236.69 | 2021-2024 | Mitraclip, Ensite Precision, Confirm Rx |
| Abiomed | $576.74 | 2019-2023 | Impella |
| Biotronik INC. | $518.14 | 2019-2025 | Biomonitor |
| Atricure, INC. | $427.34 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $235.75 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $210.18 | 2019-2024 | Rotablator Rotational Atherectomy System Console Kit |
| Astrazeneca Pharmaceuticals Lp | $207.07 | 2019-2025 | Farxiga |
| Pfizer INC. | $181.62 | 2020-2025 | |
| Livanova USA, INC. | $161.18 | 2021-2023 | Lifesparc |
| Biosense Webster, INC. | $153.61 | 2022-2025 | Nuvision Ice Catheter |
| Philips North America LLC | $131.16 | 2021-2024 | (9274) Lld |
| Medtronic, INC. | $122.59 | 2025 | Micra |
| Getinge USA Sales, LLC | $102.19 | 2023 | Cardiohelp |
| E.R. Squibb & Sons, L.L.C. | $68.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.03 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $46.11 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.75 | 2019-2023 | Lifevest |
| Teleflex LLC | $35.46 | 2025 | Guideliner V3 Catheter |
| W. L. Gore & Associates, INC. | $21.94 | 2023 | Gore Cardioform Septal Occluder |
| Amgen INC. | $21.80 | 2019 | |
| Irhythm Technologies, INC. | $15.17 | 2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $14.76 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Angiodynamics, INC. | $14.74 | 2024 | Alphavac |
| Acerus Pharmaceuticals Corporation | $14.63 | 2021 | |
| Sanofi-Aventis U.S. LLC | $12.95 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Chu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.